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Abstract
© 2016 Wiley  Periodicals,  Inc.  Nitric  oxide  (NO)-deficiency as  it  occurs  during endothelial
dysfunction activates the endothelin-1 (ET-1) system and increases the expression of receptor
activity modifying protein (RAMP)-1 that acts as a chaperon for calcium-sensing receptors (CaR)
that have recently been identified to improve cardiac function. Here, we hypothesized that ET-1
increases the cardiac expression of CaR and thereby induces an adaptive type of hypertrophy.
Expressions  of  RAMP-1,  endothelin  receptors,  and  CaR  were  analyzed  by  RT-PCR  in  left
ventricular tissues of L-NAME-treated rats. Effects of ET-1 on CaR expression and cell function
(load free cell shortening) were analyzed in adult rat ventricular cardiomyocytes. siRNA directed
against CaR and RAMP-1 was used to investigate a causal relationship. PD142893 and BQ788
were used to dissect the contribution of ET B1 , ET B2 , and ET A receptors. Non-specific NO
synthase inhibition with L-Nitro arginine methyl ester (L-NAME) caused a cardiac upregulation of
ET B receptors and CaR suggesting a paracrine effect of ET-1 on cardiomyocytes. Indeed, ET-1
induced  the  expression  of  CaR  in  cultured  cardiomyocytes.  Under  these  conditions,
cardiomyocytes increased cell size (hypertrophy) but maintained normal function. Inhibition of
ET A and ET B1 receptors led to ET-1-dependent reduction in cell shortening and attenuated up-
regulation of CaR. Down-regulation of RAMP-1 reduced CaR responsiveness. In conclusion, ET-1
causes an adaptive type of hypertrophy by up-regulation of CaR in cardiomyocytes via ET A
and/or ET B1 receptors. J. Cell. Physiol. 232: 2508–2518, 2017. © 2016 Wiley Periodicals, Inc.
http://dx.doi.org/10.1002/jcp.25612
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